Slate Bio pulls in $1.75m

Slate Bio Inc, a pre-clinical stage biotechnology company that spun out of the University of Virginia, has raised $1.75 million in financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this